Other grades of this product :
| Ferric carboxymaltose Basic information |
| Product Name: | Ferric carboxymaltose | | Synonyms: | Ferinject;Ferric carboxymaltose;Injectafer;Iron Dextri-Maltose;Ferric Carboxymaltos;Ferric carboxymahose;Injectafer USP/EP/BP | | CAS: | 9007-72-1 | | MF: | C39H63FeO39 | | MW: | 1211.73912 | | EINECS: | 813-933-0 | | Product Categories: | API;9007-72-1 | | Mol File: | 9007-72-1.mol |
| Ferric carboxymaltose Chemical Properties |
| Ferric carboxymaltose Usage And Synthesis |
| Clinical Use | Ferric carboxymaltose complex:Treatment of iron deficiency anaemia (when oral
treatment is ineffective or contraindicated) | | Drug interactions | Potentially hazardous interactions with other drugs
Dimercaprol: avoid concomitant use.
Oral iron: reduced absorption | | Metabolism | Most absorbed iron is bound to transferrin and
transported to the bone marrow where it is incorporated
into haemoglobin; the remainder is contained within the
storage forms, ferritin or haemosiderin, or as myoglobin,
with smaller amounts occurring in haem-containing
enzymes or in plasma bound to transferrin. Only very
small amounts of iron are excreted as the majority
released after the destruction of the haemoglobin
molecule is re-used. |
| Ferric carboxymaltose Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye